Rasio bathi operasi 4D Molecular Therapeutics Inc (FDMT)

4D Molecular Therapeutics leads in gene therapy through the precise delivery of DNA into organs. Strict ESG standards ensure laboratory safety and energy efficiency. Experienced management strictly adheres to R&D plans. The operating margin trend captures the business's actual profitability without subjective assessments, and -226.00 shows the level of this metric at the current stage.
Rincian analitis lan laporan data perusahaan 4D Molecular Therapeutics (FDMT)

For 4D Molecular Therapeutics (FDMT), the operating income level as a percentage of revenue reflects the efficiency of cost management regarding its elite staff of biologists. This indicator measures the share of profit from core operations before interest and taxes. The calculation is based on the ratio of the operating result to the company's total turnover. A decline in margin signals rising credit risks, while a stable figure confirms capital resilience when financing costly gene research.